Placebo-treated patients with diabetes commonly experienced a reduction in HbA1c, more markedly in augmented vs exclusively placebo-controlled treatment arms.
The rise of brain glucose levels is blunted during hyperglycemia in adults with obesity and type 2 diabetes mellitus.
Data from 2550 patients indicated a possible relationship between admission hyperglycemia and poststroke infection.
Children born to mothers with gestational diabetes had elevated rates of abnormal glucose tolerance and were more likely to be overweight or obese.
A new ADA and EASD position statement along with the ADA's revised Standards of Medical Care in Diabetes have surprising updates.
Type 1 diabetes patients experienced improved glucose control and less hypoglycemia with use of an artificial pancreas vs. sensor-augmented pump therapy.
Artificial sweeteners can potentially make blood glucose levels rise despite containing no calories.
Endocrinology Advisor Articles
- ACP Defends Higher Blood Glucose Targets for Type 2 Diabetes
- Updated Clinical Practice Guidelines on Testosterone Therapy in Men With Hypogonadism
- Semaglutide May Be Useful for Treating Obesity in People Without Diabetes
- Once-Daily Oral Contraceptive for Men Shows Promise
- HbA1c Levels Affect Serum Phospholipids, Inflammation inT2D, CVD
- American College of Physicians Releases 4 Guidelines for HbA1c Targets in T2D
- Dyslipidemia Drug Indications
- No Difference in Weight Loss Outcomes With Low-Fat vs Low-Carbohydrate Diet
- Damaging Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture
- Gastric Bypass Surgery Linked to Increased Risk for Nonvertebral Fractures
- Common Plant-Derived Oils May Contain Endocrine-Disrupting Chemicals
- Red Meat Consumption Linked to Insulin Resistance and Steatohepatitis
- Effect of High Androgen Levels on Cardiovascular Risk in Postmenopausal Women
- Fertility in Women Negatively Affected by Asthma Medications
- Glucocorticoid Use in COPD Does Not Increase Fracture Risk